Each year we award The BMJ editors’ prize for “persistence and courage in speaking truth to power.” The list of previous winners reads like a roll of honour: Peter Wilmshurst, Clare Gerada, Martin McKee, Susan Bewley, Trish Greenhalgh, Robin Stott, Jenny Vaughan, and David Nicholl. These are people who have bravely called out wrongdoing or have paved a compelling path for doing right, often through their writings in The BMJ. At the end of last year the prize went to Allyson Pollock, who is interviewed this week.1
Why should we prize these people so highly? Because it takes determination, diligence, and skill to speak out effectively, to use data and judgment, to avoid the easy resort to polemic or personal attack, and to balance necessary criticism with constructive ideas. Because it means saying unpopular things that people in power don’t want to hear.
We know that these few prize winners represent many others, working across healthcare around the world, who have shown immense courage, sometimes quietly, sometimes alienating themselves from colleagues, sometimes risking their careers and even their lives.
Supporting them and the issues they champion is part of The BMJ’s role, and in this week’s print journal we have published articles that reflect just some of the many issues that need attention. With services at full stretch because of the surge in covid-19 cases, health professionals are speaking out.2 The vaccine rollout is faltering and patchy,3despite governments having had months to prepare.4 Hopes of global vaccine equity look slim,567 and more needs to be done to reach ethnic minority communities.8 Retired doctors wishing to volunteer as vaccinators have been mired in unnecessary bureaucracy.9
A decision in the UK to extend the gap between vaccine doses has led to confusion and accusations that the government and its advisers have abandoned science.1011 We have tried to answer the most pressing questions raised by this unexpected change.12 The implications for public trust and vaccine uptake remain to be seen.13 But let us at least have the data behind the decision,14 and indeed the data from all the vaccine trials.15 On a positive note, because junior doctors spoke out, the UK regulator has responded to concerns about women who are breastfeeding being advised against having the vaccine16; and because patients spoke out, there is progress—however slow—towards a register of doctors’ financial interests.17
Not everyone can or will want to speak out. For those of you looking to make a difference in other ways, there is our charity appeal.18 We have passed previous records in the amount already donated. Families in need will thank you for your generosity.
Read the article here: https://www.bmj.com/content/372/bmj.n24
- ↵Mahase E. “In the 1980s NHS there wasn’t today’s climate of fear around speaking out”—Allyson Pollock. BMJ2021;372:m4930doi:10.1136/bmj.m4930.FREE Full TextGoogle Scholar
- ↵Coombes R. Covid-19: Frontline doctors speak out about struggle to maintain care standards. BMJ2020;371:m4971.doi:10.1136/bmj.m4971 pmid:33384300FREE Full TextGoogle Scholar
- ↵Mahase E. Covid-19: Logistical problems frustrate GPs ready to deliver vaccine in England. BMJ2020;371:m4849.doi:10.1136/bmj.m4849 pmid:33323366FREE Full TextGoogle Scholar
- ↵McGregor J. Vaccination rollout: there is no time to get this wrong. BMJ Opinion. 7 Jan 2021. https://blogs.bmj.com/bmj/2021/01/07/jane-mcgregor-vaccination-rollout-there-is-no-time-to-get-this-wrong.
- ↵So AD, Woo J. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ2020;371:m4750.doi:10.1136/bmj.m4750 pmid:33323376Abstract/FREE Full TextGoogle Scholar
- ↵Wang W, Wu Q, Yang J, et al. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study. BMJ2020;371:m4704. doi:10.1136/bmj.m4704 pmid:33323388Abstract/FREE Full TextGoogle Scholar
- ↵Schwartz JL. Equitable global access to coronavirus disease 2019 vaccines. BMJ2020;371:m4735.doi:10.1136/bmj.m4735 pmid:33323384FREE Full TextGoogle Scholar
- ↵Hanif W, Ali SN, Patel K, Khunti K. Cultural competence in covid-19 vaccine rollout. BMJ2020;371:m4845doi:10.1136/bmj.m4845.FREE Full TextGoogle Scholar
- ↵Rimmer A. Covid-19: Health secretary vows to reduce bureaucracy faced by vaccination volunteers. BMJ2021;372:n13.doi:10.1136/bmj.n13 pmid:33397687FREE Full TextGoogle Scholar
- ↵Pierce B. We need clear and simple upfront messaging on covid-19 vaccines. BMJ Opinion. 5 Jan 2021. https://blogs.bmj.com/bmj/2021/01/05/benjamin-f-pierce-we-need-clear-and-simple-upfront-messaging-on-covid-19-vaccines.
- ↵Mahase E. Covid-19: Order to reschedule and delay second vaccine dose is “totally unfair,” says BMA. BMJ2020;371:m4978.doi:10.1136/bmj.m4978 pmid:33384299FREE Full TextGoogle Scholar
- ↵Iacobucci G, Mahase E. Covid-19 vaccination: What’s the evidence for extending the dosing interval?BMJ2021;372:n18doi:10.1136/bmj.n18.FREE Full TextGoogle Scholar
- ↵Salisbury H. Helen Salisbury: Don’t squander patients’ trust in the vaccine rollout. BMJ2021;372:n3.doi:10.1136/bmj.n3 pmid:33397643FREE Full TextGoogle Scholar
- ↵Robertson J. Covid-19 vaccines: to delay or not to delay second doses. BMJ Opinion. 6 Jan 2021. https://blogs.bmj.com/bmj/2021/01/05/covid-19-vaccines-to-delay-or-not-to-delay-second-doses.
- ↵Doshi P. Pfizer and Moderna’s “95% effective” vaccines—we need more details and the raw data. BMJ Opinion. 4 Jan 2021. https://blogs.bmj.com/bmj/2021/01/04/peter-doshi-pfizer-and-modernas-95-effective-vaccines-we-need-more-details-and-the-raw-data.
- ↵Hare H, Womersley K. Why were breastfeeding women in the UK denied the covid-19 vaccine?BMJ2021;372:n4doi:10.1136/bmj.n4.FREE Full TextGoogle Scholar
- ↵Dyer C. Where the mesh inquiry leaves us regarding a register of doctors’ interests. BMJ2021;372:m4839doi:10.1136/bmj.m4839.FREE Full TextGoogle Scholar
- ↵Feinmann J. Community support that’s more than a sticking plaster. BMJ2021;372:m4959doi:10.1136/bmj.m4959.FREE Full TextGoogle Scholar